Strengthening the Role of the IBC in the 21st Century

R. Mark Buller, Nancy D. Connell, Steven S. Morse, Mark Campbell, Raymond C. Tait

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The US government (USG) has not fully implemented a robust system to evaluate dual-use research (DUR). In particular, the USG has failed to effectively fund, support, and expand the role of the local Institutional Biosafety Committee in the oversight of DUR and in the changing scientific landscape; a comprehensive education program for all in life sciences research with regard to the dual-use dilemma has not been forthcoming; and finally, there has been no systematic evaluation of the impact of USG policy, regulations, and guidance on an institution's cost structure and on scientific discovery. We detail our judgments on current USG DUR policy and provide recommendations for future oversight of DUR from our perspective as senior administrators and laboratory scientists charged with the responsibility of conducting life-sciences research in an era of increasing regulatory requirements and decreasing federal support.

Original languageEnglish (US)
Title of host publicationEnsuring National Biosecurity
Subtitle of host publicationInstitutional Biosafety Committees
PublisherElsevier Inc.
Pages217-246
Number of pages30
ISBN (Print)9780128018859
DOIs
StatePublished - Feb 8 2016
Externally publishedYes

Keywords

  • 2011 influenza A/H5N1 controversy
  • Dual-use research
  • Institutional Biosafety Committee
  • National Institutes of Health Guidelines
  • Oversight of dual-use research of concern (DURC)
  • Protocol review

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Strengthening the Role of the IBC in the 21st Century'. Together they form a unique fingerprint.

Cite this